Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study

NCT05559398 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Acute
Stroke, Ischemic

Interventions

DRUG: Glenzocimab
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris